At the last check on Friday, CME Group Inc.’s (NASDAQ:CME) stock traded at $204.03. The average number of shares traded per day over the past five days has been 1,185,825 shares. 1 time new highs have been achieved over the past 5 days, with a -$1.69 fall in that time frame. In the last twenty days, the average volume was 1,451,266, while in the previous 50 days, it was 1,494,608.
Since last month, CME stock rose 8.87%. Shares of the company fell to $186.11 on 07/20/23, the lowest level in the past month. A 52-week high of $209.31 was reached on 08/09/23 after having rallying from a 52-week low of $162.26. Since the beginning of this year, CME’s stock price has risen by 21.33% or $35.92, and marked a new high 20 times. However, the stock has declined by -2.52% since its 52-week high.
CME stock investors should be aware that CME Group Inc. (CME) stock had its last reported insider trading activity 3 days ago on Aug 15. Holzrichter Julie, the Sr MD Chief Operating Officer of the company, disposed of 6,000 shares for $205.47 on Aug 15. It resulted in a $1,232,821 divestment by the insider. Bitsberger Timothy S. sold 800 shares at an average price of $205.92 on Aug 11. The insider now owns 10,841 shares following the transaction. On Aug 10, Sr MD Chief Commercial Officer Winkler Julie sold 6,262 shares at $207.00 apiece. The transaction was valued at $1,296,234.
Valuation Metrics
Right now, CME Group Inc. (CME) has a P/E ratio of about 24.92. The stock’s beta is 0.41. Besides these, the trailing price-to-sales (P/S) ratio of 7.30, the price-to-book (PB) ratio of 2.63, and the price-to-cash flow ratio of 23.50 may also be considered.
The latest dividend of $1.10 per share was paid out, remained unchanged from last year’s $1.10.
Financial Health
In the three months ended June 29, CME Group Inc.’s quick ratio stood at 1.00, while its current ratio was 1.00, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.13, and the total debt-to-equity ratio was 0.13. In the year ended June 29, operating margins totaled 79.20%. Based on annual data, CME earned $2.0 billion in gross profit and brought in $5.02 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 14.50%. Return on equity (ROE) for the past 12 months was 10.70%.
In CME Group Inc.’s quarter-end financial report for June 29, it reported total debt of $3.42 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. CME’s revenue rose 9.04% to $1.44 billion during the quarter, while net income inched up to $1.36 billion. While analysts expected CME Group Inc. to report $2.2 quarterly earnings, the actual figure was $2.3 per share, beating the consensus estimate by 4.50%. During the quarter, the company generated $927.9 million in EBITDA. The liabilities of CME Group Inc. were 123.48 billion at the end of its most recent quarter ended June 29, and its total debt was $3.91 billion. The value of shareholders’ equity is $359.75 million.
Technical Picture
This quick technical analysis looks at CME Group Inc.’s (CME) price momentum. With a historical volatility rate of 11.69%, the RSI 9-day stood at 58.26% on 17 August.
With respect to its five-day moving average, the current CME Group Inc. price is down by -0.82% percent or -$1.69. At present, CME shares trade +7.83% above its 20-day simple moving average and +10.30% percent above its 100-day simple moving average. However, the stock is currently trading approximately +11.79% above its SMA50 and +17.76% above its SMA200.
Stochastic coefficient K was 59.25% and Stochastic coefficient D was 64.91%, while ATR was 2.92. Given the Stochastic reading of 53.74% for the 14-day period, the RSI (14) reading has been calculated as 62.87%. As of today, the MACD Oscillator reading stands at -0.62, while the 14-day reading stands at 0.16.
Analyst Ratings
Barclays launched its rating on CME Group Inc. (NASDAQ: CME) to an Overweight in a note to investors on June 28, 2023. CME Group Inc. (CME) has been rated Overweight by analysts. According to 2 brokerage firms, CME is a sell, and 6 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 2 analysts rate CME Group Inc. stock as buy, with 8 recommending it as overweight.
With a median target price of $215.00, the current consensus forecast for the stock is $155.00 – $250.00. Based on these forecasts, analysts predict CME Group Inc. (CME) will achieve an average price target of $208.13.
